SAD includes 95% of patients aged 65 years or older, while 5% of patients develop FAD before 65 years of age since they carry rare genetic mutations in presenilin 1 (PS 1) and presenilin 2 (PS 2) or amyloid precursor protein (APP) genes [94]. Here, PSEN2 is linked to familial Alzheimer disease.